Published in Am J Kidney Dis on December 01, 2003
Pulmonary vasculitis. Proc Am Thorac Soc (2006) 2.54
Bench-to-bedside review: pulmonary-renal syndromes--an update for the intensivist. Crit Care (2007) 1.10
Update on diffuse alveolar hemorrhage and pulmonary vasculitis. Immunol Allergy Clin North Am (2012) 1.07
Anti-neutrophil cytoplasmic (ANCA) and anti-glomerular basement membrane (GBM) autoantibodies in necrotizing and crescentic glomerulonephritis. Semin Immunopathol (2007) 1.01
Diffuse alveolar hemorrhage. Tuberc Respir Dis (Seoul) (2013) 0.94
Progress in treatment of ANCA-associated vasculitis. Arthritis Res Ther (2012) 0.93
The role of plasmapheresis in critical illness. Crit Care Clin (2012) 0.88
Chapter 13: Pauci-immune focal and segmental necrotizing glomerulonephritis. Kidney Int Suppl (2011) (2012) 0.86
Severe hemorrhagic cystitis associated with prolonged oral cyclophosphamide therapy: case report and literature review. Rheumatol Int (2008) 0.85
Treatment of renal manifestations of ANCA-associated vasculitis. J Nephropathol (2013) 0.84
Glomerular disease: ANCA-associated GN--to PLEX or not to PLEX? Nat Rev Nephrol (2013) 0.83
Diffuse alveolar hemorrhage in lupus nephritis complicated by microscopic polyangiitis. Clin Exp Nephrol (2011) 0.81
Prompt plasmapheresis successfully rescue pulmonary-renal syndrome caused by ANCA-negative microscopic polyangiitis. Clin Rheumatol (2009) 0.80
Role of therapeutic plasmapheresis in ANCA-associated vasculitis. Pediatr Nephrol (2015) 0.80
Two cases of extrapulmonary onset granulomatosis with polyangiitis which caused diffuse alveolar haemorrhage. Respir Med Case Rep (2014) 0.79
Pulmonary renal syndrome associated with Wegener's granulomatosis: a case report and review of literature. Clin Exp Nephrol (2010) 0.78
Benefits and limitations of plasmapheresis in renal diseases: an evidence-based approach. J Artif Organs (2010) 0.78
Tacrolimus as a reinforcement therapy for a patient with MPO-ANCA-associated diffuse alveolar hemorrhage. Clin Rheumatol (2006) 0.76
Pathways to renal biopsy and diagnosis among patients with ANCA small-vessel vasculitis. Clin Exp Rheumatol (2013) 0.75
Recent advances in understanding and treating vasculitis. F1000Res (2016) 0.75
Acute spontaneously resolving pulmonary vasculitis: a case report. Case Reports Immunol (2012) 0.75
MRSA induced pulmonary-renal syndrome. Respir Med Case Rep (2016) 0.75
The Prevalence and Management of Pauci-Immune Glomerulonephritis and Vasculitis in Western Countries. Kidney Dis (Basel) (2015) 0.75
Atypical Endobronchial Carcinoid with Postobstructive Pneumonia Obscuring the Diagnosis of Granulomatosis with Polyangiitis. Case Rep Rheumatol (2015) 0.75
Leukocytoclastic Vasculitis with Systemic Involvement Associated with Ciprofloxacin Therapy: Case Report and Review of the Literature. Cureus (2016) 0.75
American Society of Nephrology quiz and questionnaire 2014: glomerular diseases. Clin J Am Soc Nephrol (2015) 0.75
Successful Use of Plasma Exchange in the Treatment of Corticosteroid-Refractory Eosinophilic Granulomatosis with Polyangiitis Associated with Gastrointestinal Manifestations. Case Reports Immunol (2016) 0.75
Patients with ANCA-associated vasculitis admitted to the intensive care unit with acute vasculitis manifestations: a retrospective and comparative multicentric study. Ann Intensive Care (2017) 0.75
The Effects of Plasma Exchange on Severe Vasculitis with Diffuse Alveolar Hemorrhage. Intern Med (2017) 0.75
ANCA Glomerulonephritis and Vasculitis. Clin J Am Soc Nephrol (2017) 0.75
Antineutrophil cytoplasmic autoantibodies specific for myeloperoxidase cause glomerulonephritis and vasculitis in mice. J Clin Invest (2002) 5.42
Focal segmental glomerulosclerosis. N Engl J Med (2011) 3.77
Predictors of relapse and treatment resistance in antineutrophil cytoplasmic antibody-associated small-vessel vasculitis. Ann Intern Med (2005) 3.18
Autoimmunity is triggered by cPR-3(105-201), a protein complementary to human autoantigen proteinase-3. Nat Med (2003) 2.85
Clinical trial of focal segmental glomerulosclerosis in children and young adults. Kidney Int (2011) 2.43
Alternative complement pathway in the pathogenesis of disease mediated by anti-neutrophil cytoplasmic autoantibodies. Am J Pathol (2007) 2.41
Predictors of treatment resistance and relapse in antineutrophil cytoplasmic antibody-associated small-vessel vasculitis: comparison of two independent cohorts. Arthritis Rheum (2008) 2.26
Discrepancy between Medical Evidence Form 2728 and renal biopsy for glomerular diseases. Clin J Am Soc Nephrol (2010) 2.25
Venous thromboembolism in patients with membranous nephropathy. Clin J Am Soc Nephrol (2011) 2.18
Classification of antineutrophil cytoplasmic autoantibody vasculitides: the role of antineutrophil cytoplasmic autoantibody specificity for myeloperoxidase or proteinase 3 in disease recognition and prognosis. Arthritis Rheum (2012) 2.17
Pathogenesis of antineutrophil cytoplasmic autoantibody-associated small-vessel vasculitis. Annu Rev Pathol (2013) 2.02
Epitope specificity determines pathogenicity and detectability in ANCA-associated vasculitis. J Clin Invest (2013) 1.99
The role of neutrophils in the induction of glomerulonephritis by anti-myeloperoxidase antibodies. Am J Pathol (2005) 1.97
Association between thyroid disease and its treatment with ANCA small-vessel vasculitis: a case-control study. Nephrol Dial Transplant (2007) 1.89
Epigenetic basis for aberrant upregulation of autoantigen genes in humans with ANCA vasculitis. J Clin Invest (2010) 1.87
Anti-LAMP-2 antibodies are not prevalent in patients with antineutrophil cytoplasmic autoantibody glomerulonephritis. J Am Soc Nephrol (2011) 1.82
Periodontal disease adversely affects the survival of patients with end-stage renal disease. Kidney Int (2009) 1.74
Patients with antineutrophil cytoplasmic antibody-associated vasculitis have defective Treg cell function exacerbated by the presence of a suppression-resistant effector cell population. Arthritis Rheum (2013) 1.70
Design of the Nephrotic Syndrome Study Network (NEPTUNE) to evaluate primary glomerular nephropathy by a multidisciplinary approach. Kidney Int (2013) 1.69
Aggravation of anti-myeloperoxidase antibody-induced glomerulonephritis by bacterial lipopolysaccharide: role of tumor necrosis factor-alpha. Am J Pathol (2005) 1.65
Rituximab therapy for membranous nephropathy: a systematic review. Clin J Am Soc Nephrol (2009) 1.62
SCreening for Occult REnal Disease (SCORED): a simple prediction model for chronic kidney disease. Arch Intern Med (2007) 1.56
The clinical course of ANCA small-vessel vasculitis on chronic dialysis. Kidney Int (2009) 1.54
DRB1*15 allele is a risk factor for PR3-ANCA disease in African Americans. J Am Soc Nephrol (2011) 1.51
Cutaneous and systemic manifestations of drug-induced vasculitis. Ann Pharmacother (2002) 1.48
Pathogenesis of vascular inflammation by anti-neutrophil cytoplasmic antibodies. J Am Soc Nephrol (2006) 1.48
The effect of cholesterol reduction with cholestyramine on renal function. Am J Kidney Dis (2005) 1.46
Association of silica exposure with anti-neutrophil cytoplasmic autoantibody small-vessel vasculitis: a population-based, case-control study. Clin J Am Soc Nephrol (2007) 1.46
C5a receptor (CD88) blockade protects against MPO-ANCA GN. J Am Soc Nephrol (2013) 1.38
Clinical trials treating focal segmental glomerulosclerosis should measure patient quality of life. Kidney Int (2010) 1.38
Granulomatosis with polyangiitis (Wegener's): an alternative name for Wegener's granulomatosis. Ann Rheum Dis (2011) 1.33
Periodontal disease is associated with renal insufficiency in the Atherosclerosis Risk In Communities (ARIC) study. Am J Kidney Dis (2005) 1.31
High prevalence of sickle cell trait in African Americans with ESRD. J Am Soc Nephrol (2010) 1.23
Bone marrow-derived cells are sufficient and necessary targets to mediate glomerulonephritis and vasculitis induced by anti-myeloperoxidase antibodies. J Am Soc Nephrol (2006) 1.20
Glucocorticoids and relapse and infection rates in anti-neutrophil cytoplasmic antibody disease. Clin J Am Soc Nephrol (2011) 1.20
The effect of conflicting medication information and physician support on medication adherence for chronically ill patients. Patient Educ Couns (2009) 1.18
Molecular cloning, genomic structure, and expression analysis of MUC20, a novel mucin protein, up-regulated in injured kidney. J Biol Chem (2003) 1.17
ANCA are pathogenic--oh yes they are! J Am Soc Nephrol (2002) 1.15
Circumvention of normal constraints on granule protein gene expression in peripheral blood neutrophils and monocytes of patients with antineutrophil cytoplasmic autoantibody-associated glomerulonephritis. J Am Soc Nephrol (2004) 1.14
Disease-specific risk of venous thromboembolic events is increased in idiopathic glomerulonephritis. Kidney Int (2011) 1.13
Decreased CD5⁺ B cells in active ANCA vasculitis and relapse after rituximab. Clin J Am Soc Nephrol (2013) 1.12
A clinical tool to measure the components of health-care transition from pediatric care to adult care: the UNC TR(x)ANSITION scale. Ren Fail (2012) 1.09
Predictors of relapse and end stage kidney disease in proliferative lupus nephritis: focus on children, adolescents, and young adults. Clin J Am Soc Nephrol (2009) 1.09
A novel subset of memory B cells is enriched in autoreactivity and correlates with adverse outcomes in SLE. Clin Immunol (2008) 1.08
Long-term glycemic control measurements in diabetic patients receiving hemodialysis. Am J Kidney Dis (2002) 1.08
Positive association of renal insufficiency with agriculture employment and unregulated alcohol consumption in Nicaragua. Ren Fail (2010) 1.07
Pathogenesis of antineutrophil cytoplasmic autoantibody vasculitis. Curr Opin Nephrol Hypertens (2011) 1.06
Health-related quality of life for patients with vasculitis and their spouses. Arthritis Rheum (2009) 1.06
NPHS2 variation in focal and segmental glomerulosclerosis. BMC Nephrol (2008) 1.04
A pilot study using mycophenolate mofetil in relapsing or resistant ANCA small vessel vasculitis. Nephrol Dial Transplant (2005) 1.02
ANCA patients have T cells responsive to complementary PR-3 antigen. Kidney Int (2008) 1.02
Nosology of primary vasculitis. Curr Opin Rheumatol (2007) 1.01
Community perspectives on kidney disease and health promotion from at-risk populations in rural North Carolina, USA. Rural Remote Health (2010) 1.01
Anti-neutrophil cytoplasmic (ANCA) and anti-glomerular basement membrane (GBM) autoantibodies in necrotizing and crescentic glomerulonephritis. Semin Immunopathol (2007) 1.01
Fostering innovation, advancing patient safety: the kidney health initiative. Clin J Am Soc Nephrol (2013) 1.00
Successful treatment of diffuse alveolar hemorrhage with activated factor VII. Ann Intern Med (2004) 0.99
Expression profile of leukocyte genes activated by anti-neutrophil cytoplasmic autoantibodies (ANCA). Kidney Int (2002) 0.98
Granulomatosis with polyangiitis (Wegener's): an alternative name for Wegener's granulomatosis. J Am Soc Nephrol (2011) 0.98
Abnormal bone turnover in cystic fibrosis adults. Osteoporos Int (2002) 0.97
New insight into the pathogenesis of vasculitis associated with antineutrophil cytoplasmic autoantibodies. Curr Opin Rheumatol (2008) 0.97
Novel effects of neutrophil-derived proteinase 3 and elastase on the vascular endothelium involve in vivo cleavage of NF-kappaB and proapoptotic changes in JNK, ERK, and p38 MAPK signaling pathways. J Am Soc Nephrol (2002) 0.97
Bilateral hematogenous Pseudomonas aeruginosa endophthalmitis after lung transplantation. Am J Transplant (2006) 0.96
Predictors of treatment outcomes in ANCA-associated vasculitis with severe kidney failure. Clin J Am Soc Nephrol (2014) 0.96
Proteinase 3 sidesteps caspases and cleaves p21(Waf1/Cip1/Sdi1) to induce endothelial cell apoptosis. Kidney Int (2004) 0.95
Antibodies with dual reactivity to plasminogen and complementary PR3 in PR3-ANCA vasculitis. J Am Soc Nephrol (2008) 0.94
Myeloperoxidase interacts with endothelial cell-surface cytokeratin 1 and modulates bradykinin production by the plasma Kallikrein-Kinin system. Am J Pathol (2007) 0.93
Obesity, albuminuria, and urinalysis findings in US young adults from the Add Health Wave III study. Clin J Am Soc Nephrol (2007) 0.93
Development and initial evaluation of a measure of self-management for adults with antineutrophil cytoplasmic antibody-associated small-vessel vasculitis. Arthritis Rheum (2007) 0.93
Rituximab in ANCA-associated disease. N Engl J Med (2010) 0.92
Various forms of life in antineutrophil cytoplasmic antibody-associated vasculitis. Ann Intern Med (2006) 0.92
The impact of vasculitis on patients' social participation and friendships. Clin Exp Rheumatol (2012) 0.92
Calcineurin inhibitor-induced nephrotoxicity and renal expression of P-glycoprotein. Pharmacotherapy (2005) 0.91
Gene expression profiles of circulating leukocytes correlate with renal disease activity in IgA nephropathy. Kidney Int (2004) 0.91
Survival of liver transplant candidates with acute renal failure receiving renal replacement therapy. Kidney Int (2005) 0.91
Cytochrome P450 3A5 expression in the kidneys of patients with calcineurin inhibitor nephrotoxicity. Nephrol Dial Transplant (2007) 0.91
Controversies in small vessel vasculitis--comparing the rheumatology and nephrology views. Curr Opin Rheumatol (2007) 0.90
Cyclophosphamide and 4-hydroxycyclophosphamide pharmacokinetics in patients with glomerulonephritis secondary to lupus and small vessel vasculitis. Br J Clin Pharmacol (2012) 0.89
Pharmacokinetics of mycophenolic acid in patients with lupus nephritis. Pharmacotherapy (2009) 0.89